TR

TriMas Corporation

TRSConsumer CyclicalNASDAQ

Packaging & Containers · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$645.7M
+2.4% YoY
Net Income
$120.1M
+395.4% YoY
EBITDA
$99.3M
+23.7% YoY
Free Cash Flow
$293.6M

Scan Results

Daily timeframe
3 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20CONFIRMED▲ Above MA150+0.4% from MA150, price crossed above
▲ MACD Positive CrossoverHistogram +0.0819, positive momentum
Oct 19CONFIRMED▲ Above MA200+0.9% from MA200, price crossed above
▲ MACD Positive CrossoverHistogram +0.0272, positive momentum
About TriMas Corporation

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace and defense, and industrial markets worldwide. The $1.42B market capitalization puts TRS squarely in small-cap range for its industry. The company operates through Packaging and Specialty Products segments.

Where TRS stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, TRS finished 0.36% above its 150-day moving average ($39.29) and 2.60% above its 200-day moving average ($38.43). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is TRS overbought or oversold?

At the October 20, 2026 close, TRS's RSI(14) was 51.3, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.42B
P/E (TTM)16.10
Fwd P/E18.60
EPS$2.46
Beta0.61
52W Change+1.4%
Dividend Yield0.40%
ROE7.7%
Analysis

With $1.24B in cash and $437.8M in debt, TRS maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company generates $293.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 7.7% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.0% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $883.8M (2022) to $645.7M (2025), a 27% decline worth watching.

TRS's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. With cash comfortably exceeding debt, TRS has financial flexibility that may help navigate uncertain periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing TRS.

Links
More Consumer Cyclical stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms